Cooperative roles for emmprin and LYVE-1 in the regulation of chemoresistance for primary effusion lymphoma

The PI3K/Akt Pathway as a Target in the Treatment of Hematologic Malignancies

(2012) Kiyotaka Kawauchi et al.   Anti-Cancer Agents in Medicinal Chemistry

Reduction of Hyaluronan-CD44–Mediated Growth, Migration, and Cisplatin Resistance in Head and Neck Cancer Due to Inhibition of Rho Kinase and PI-3 Kinase Signaling

(2010) Carlos Torre et al.   ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY

Direct Activation of Emmprin and Associated Pathogenesis by an Oncogenic Herpesvirus

(2010) Z. Qin et al.   CANCER RESEARCH

Transcription factor Sp1 regulates expression of cancer-associated molecule CD147 in human lung cancer

(2010) Ling-Min Kong et al.   CANCER SCIENCE

NF- B Activation Limits Airway Branching through Inhibition of Sp1-Mediated Fibroblast Growth Factor-10 Expression

(2010) J. T. Benjamin et al.   JOURNAL OF IMMUNOLOGY

EMMPRIN activates multiple transcription factors in cardiomyocytes, and induces interleukin-18 expression via Rac1-dependent PI3K/Akt/IKK/NF-κB andMKK7/JNK/AP-1 signaling

(2010) Balachandar Venkatesan et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Upregulation of xCT by KSHV-Encoded microRNAs Facilitates KSHV Dissemination and Persistence in an Environment of Oxidative Stress

(2010) Zhiqiang Qin et al.   PLoS Pathogens

PI-3-K and AKT: Onto the mitochondria☆

(2009) Bangyan L. Stiles   ADVANCED DRUG DELIVERY REVIEWS

NFκB signaling in carcinogenesis and as a potential molecular target for cancer therapy

(2009) Han-Ming Shen et al.   APOPTOSIS

Abrogating Drug Resistance in Malignant Peripheral Nerve Sheath Tumors by Disrupting Hyaluronan-CD44 Interactions with Small Hyaluronan Oligosaccharides

(2009) M. G. Slomiany et al.   CANCER RESEARCH

Hyaluronan, CD44, and Emmprin Regulate Lactate Efflux and Membrane Localization of Monocarboxylate Transporters in Human Breast Carcinoma Cells

(2009) Mark G. Slomiany et al.   CANCER RESEARCH

Inhibition of Functional Hyaluronan-CD44 Interactions in CD133-positive Primary Human Ovarian Carcinoma Cells by Small Hyaluronan Oligosaccharides

(2009) M. G. Slomiany et al.   CLINICAL CANCER RESEARCH

Immunological functions of hyaluronan and its receptors in the lymphatics

(2009) David G. Jackson   IMMUNOLOGICAL REVIEWS

Biscoclaurine alkaloid cepharanthine inhibits the growth of primary effusion lymphomain vitroandin vivoand induces apoptosisviasuppression of the NF-κB pathway

(2009) Naoko Takahashi-Makise et al.   INTERNATIONAL JOURNAL OF CANCER

Resveratrol inhibits EMMPRIN expression via P38 and ERK1/2 pathways in PMA-induced THP-1 cells

(2008) Zhouqing Huang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Interaction between CD147 and P-Glycoprotein and Their Regulation by Ubiquitination in Breast Cancer Cells

(2008) Wen-Juan Wang et al.   CHEMOTHERAPY

Targeting Hyaluronan Interactions in Malignant Gliomas and Their Drug-Resistant Multipotent Progenitors

(2008) A. G. Gilg et al.   CLINICAL CANCER RESEARCH

Hyaluronan, CD44 and Emmprin: Partners in cancer cell chemoresistance

(2008) Bryan P. Toole et al.   DRUG RESISTANCE UPDATES

Basigin-2 Is a Cell Surface Receptor for Soluble Basigin Ligand

(2008) Robert J. Belton et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Hyaluronan-mediated CD44 Interaction with p300 and SIRT1 Regulates β-Catenin Signaling and NFκB-specific Transcription Activity Leading to MDR1 and Bcl-xLGene Expression and Chemoresistance in Breast Tumor Cells

(2008) Lilly Y. W. Bourguignon et al.   JOURNAL OF BIOLOGICAL CHEMISTRY